Inflammation and neurodegeneration in Parkinson's disease
Top Cited Papers
- 1 May 2004
- journal article
- review article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 10, S3-S7
- https://doi.org/10.1016/j.parkreldis.2004.01.005
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Presence of reactive microglia in monkey substantia nigra years after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine administrationAnnals of Neurology, 2003
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Activation of microglia by human neuromelanin is NF‐κB‐dependent and involves p38 mitogen‐activated protein kinase: implications for Parkinson's diseaseThe FASEB Journal, 2003
- Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic InterventionThe Journal of Pharmacology and Experimental Therapeutics, 2003
- An inflammatory review of Parkinson’s diseaseProgress in Neurobiology, 2002
- Mice deficient in TNF receptors are protected against dopaminergic neurotoxicity: Implications for Parkinson's diseaseThe FASEB Journal, 2002
- Association of interleukin-1β polymorphisms with idiopathic Parkinson's diseaseNeuroscience Letters, 2002
- Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxideDevelopmental Brain Research, 2002
- Up-Regulated Production and Activation of the Complement System in Alzheimer's Disease BrainThe American Journal of Pathology, 1999
- Lack of toxicity of human neuromelanin to rat brain dopaminergic neuronsParkinsonism & Related Disorders, 1996